Thursday, 08 July 2021
INBRAIN Neuroelectronics collaborates with Merck to develop the next generation of bioelectronic therapies
The ICN2 and ICREA’s spin-off INBRAIN Neurolectronics starts a collaboration with the leading biotechnology company Merck. They will develop novel graphene bioelectronics devices for vagus nerve therapies, targeting severe chronic diseases.
